• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov12
Autolus Therapeutics Reports Strong Q3 2025 Financials and Positive CAR T Therapy Clinical Data
16:33
Autolus Therapeutics released FY2025 Q3 earnings on November 12 Pre-Market (EST), actual revenue USD 21.19 M (forecast USD 21.31 M), actual EPS USD -0.2972 (forecast USD -0.2208)
14:30
Autolus Therapeutics released FY2025 9 Months Earnings on November 12 Pre-Market EST, with actual revenue of USD 51.1 M and EPS of USD -0.7436
14:30
Nov5
Autolus Therapeutics to Release FY2025 Q3 Earnings on November 12 Pre-Market EST, Forecast Revenue USD 21.31 M, EPS USD -0.229
00:20
Oct20
Gil Blum gives Autolus Therapeutics a Buy Rating
10:06
Aug12
Autolus Therapeutics released FY2025 Semi-Annual Earnings on August 12 Pre-Market EST, with actual revenue of USD 29.91 M and EPS of USD -0.4436
13:30

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 21.19 M, Net Income -79.12 M, EPS -0.2972

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 20.92 M, Net Income -47.92 M, EPS -0.18

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 8.982 M, Net Income -70.16 M, EPS -0.2636

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More